300970 華綠生物
按盤價 
12.040 +0.480 (+4.152%)
12.040 +0.480 (+4.152%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.979 | 1.985 | 5.325 | 1.362 | 16.719 |
| 總資產報酬率 ROA (%) | -2.129 | 1.481 | 4.058 | 1.020 | 12.142 |
| 投入資產回報率 ROIC (%) | -2.394 | 1.644 | 4.412 | 1.116 | 13.644 | 邊際利潤分析 |
| 銷售毛利率 (%) | 0.371 | 13.522 | 16.320 | 6.657 | 27.284 |
| 營業利潤率 (%) | -9.795 | 2.727 | 10.767 | 2.943 | 22.048 |
| 息稅前利潤/營業總收入 (%) | -9.693 | 2.661 | 9.376 | 1.143 | 21.958 |
| 淨利潤/營業總收入 (%) | -9.796 | 2.647 | 10.333 | 2.816 | 21.695 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.762 | 140.938 | 85.129 | 13.344 | 92.268 |
| 價值變動淨收益/利潤總額(%) | -0.191 | 1.390 | 5.254 | 13.424 | 1.495 |
| 營業外收支淨額/利潤總額(%) | 0.008 | -3.021 | -1.175 | -1.349 | -1.513 | 償債能力分析 |
| 流動比率 (X) | 2.616 | 2.686 | 3.837 | 5.351 | 2.459 |
| 速動比率 (X) | 1.715 | 1.881 | 2.987 | 4.724 | 1.845 |
| 資產負債率 (%) | 28.985 | 26.005 | 23.118 | 23.390 | 0.269 |
| 帶息債務/全部投入資本 (%) | 13.684 | 10.088 | 13.940 | 14.557 | 14.212 |
| 股東權益/帶息債務 (%) | 574.180 | 814.013 | 599.162 | 564.466 | 573.845 |
| 股東權益/負債合計 (%) | 241.131 | 280.865 | 329.901 | 325.557 | 270.294 |
| 利息保障倍數 (X) | -94.613 | 193.875 | -7.407 | -0.649 | 92.205 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 6.840 | 5.628 | 11.833 | 16.340 | 7.114 |
| 存貨周轉天數 (天) | 72.183 | 72.141 | 75.843 | 63.962 | 60.760 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
